SlideShare a Scribd company logo
1 of 19
Activities in Regards of FMD in Georgia
National Food Agency
Vasili Basiladze
Deputy head of NFA
Chief Veterinary Officer, WOAH Delegate
1. FMD prophylactic vaccination in LR and SR;
2. FMD Risk assessment through ArcGIS;
3. FMD SP Sero-Surveillance in LR and SR;
4. FMD NSP Sero-Surveillance in LR and SR;
5. FMD Clinical investigation in candidate regions;
6. Evaluation of vaccine quality and immune responses;
7. Awareness campaign within the farmers;
8. Regional Simulation exercises;
9. Workshops and trainings;
10. OCP has been elaborated;
• FMD risk based prophylactic vaccination has been conducted in LR and SR;
• Eastern Georgia - Total number of animals (LR/SR);
• Western Georgia - Animal located in high risk area (LR/SR);
• Live animal markets, migrated animals, villages bordering with neighboring countries;
villages bordering with occupied territory;
378991
975078
1528469 1617120 1533598 1465966
1000915
1280392
858000 865394 873901
624903
12960
127022
851576
998594
917336
1534680
1660625 1183095
1499333 1366515 1376350
1154528
0
500000
1000000
1500000
2000000
2500000
3000000
3500000
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
FMD Prophilactic Vaccination 2011-2022
LR SR
• Animal Density SR/LR;
• Seasonal Migration SR/LR;
• Live Animal Market;
• Vet inspection points;
• Water sources;
• International Trade;
• Pasture;
• Animal Market;
• Quarantine Zones;
• NSP sero- surveillance in Georgia has been conducting by four risk categories:
• 1. Villages with high risk categories;
• 2. Villages with low risk categories;
• 3. Migrating animals in Eastern Georgia;
• 4. Villages in Candidate Area.
• NSP Sero- Surveillance – 5000 samples each year;
• NSP Sero- Surveillance follow-up 500 samples each year;
• SP Sero- Surveillance 500 samples each year;
15
12
6.6
8.2
5.3
4.3
5
47 46
75
39.1
62.9
71.2 70.8
0
10
20
30
40
50
60
70
80
0
2
4
6
8
10
12
14
16
2015 2016 2017 2018 2019 2020 2021
FMD SP and NSP Sero- surveillance 2015-2020 in Georgia
Non Structural proteins Structural proteins
Territory selection criteria:
• Geographically isolated territories;
• Only few entrance are available in both region;
• Strict climatic conditions;
• No Seasonal migration;
• Low animal density (1,0 animals per 1 km2);
• Historically favorable epizootic situation related to FMD;
• Low prevalence of non-structural proteins;
• 107 villages and 3 074 animals were investigated;
• Data were entered in electronic system – Epicollect 5
 VACCINE used in country - Sholkovo vaccine
• Type O: PanAsia-2
• Type A: Iran 05; G-VII
• Type Asia1: Shamir/Sindh-08
 Sampling area were selected-based on following criteria;
• Low NSP circulation area
• Area with non vaccinated animals
• Area existing with both specious (LR/SR)
• Permission of sampling from animal owners involved in the trial
The following protocol was elaborated
• Species – large and small ruminants;
• Status – animals with free from FMDV and antibodies, not vaccinated against FMD;
• Age – six to Twelve months;
• Number – totally 20 cattle and 20 sheep (9 vaccinated, 9 with revaccination and 2
control animals).
• Animal identification – individually identified (ear tag);
• Housing – animals should be kept in local area
• SEROCONVERSION POST SINGLE VACCINATION:14 DPV 60-80% seropositive animals but very fast
Ab decay (negative 90 DPV)
• Low Ab levels
• Insufficient immunity
• BOOSTER VACCINATION: Significant Ab booster 30 days after revaccination, ALL positives above the
presumed protection level
• A booster vaccination is necessary to elicit a strong and fast rise of Ab;
• Duration estimates should be planned;
• SPECIES: better immune-response in SR than in LR after a single vaccination (particularly for serotype A
and Asia1); opposite after booster vaccination.
Hot line - 1501
• First simulation exercise has been conducted in 2016;
• Second simulation exercise has been conducted in 2019;
• Next is planed in 2023;
0
100000
200000
300000
400000
500000
600000
700000
800000
2014 2015 2016 2017 2018 2019 2020 2021 2022
treatment Vaccination
LSD Vaccination 2014-2020
• 400 000 doses LSD Vaccine (SGP strain) was
purchased in 2020;
• 200 000 doses LSD Vaccine (Neethling Strain) for
was donated by EU in 2018/2020.
1650974
341461
399655
195978
279,382 712318 267933
0
200000
400000
600000
800000
1000000
1200000
1400000
1600000
1800000
2016 2017 2018 2019 2020 2021 2022
PPR prophylactic vaccination/re-vaccination in 2016-2022
• 267 933 SR were vaccinated/revaccinated in 2022;
• Active sero-survey campaign (Project) conducted in
Georgia which was funded by DTRA;
• Totally 3 200 SR has been tested under this project;
FAO has donated 400 000 doses PPR vaccine in 2020
FAO has donated 500 000 doses PPR vaccine in 2022
System includes Veterinary, Human Health,
Laboratories
System ensures quick exchange of information and
creation of database
• Since 2018 year NAITS has been operating;
Financed and Supported by Swiss and Austrian
Development
National Animal Identification and
Traceability System
Thank you for your attention

More Related Content

Similar to V. Basiladze - The PCP-FMD progress in Georgia and how it advances FAST control

Current Management Status of Highly Pathogenic Avian Influenza (HPAI) in Nepal
Current Management Status of Highly Pathogenic Avian Influenza (HPAI) in NepalCurrent Management Status of Highly Pathogenic Avian Influenza (HPAI) in Nepal
Current Management Status of Highly Pathogenic Avian Influenza (HPAI) in NepalAutistic Brain
 
Current management status of highly pathogeni8c avian influenza (hpai) in nepal
Current management status of highly pathogeni8c avian influenza (hpai) in nepalCurrent management status of highly pathogeni8c avian influenza (hpai) in nepal
Current management status of highly pathogeni8c avian influenza (hpai) in nepalkrishnaacharya22
 
Je vaccination bqa
Je vaccination bqaJe vaccination bqa
Je vaccination bqadrdduttaM
 
OS16 - 3.4.a FMD Vaccination and Post-Vaccination Monitoring in Afghanistan...
OS16 - 3.4.a   FMD Vaccination and Post-Vaccination Monitoring in Afghanistan...OS16 - 3.4.a   FMD Vaccination and Post-Vaccination Monitoring in Afghanistan...
OS16 - 3.4.a FMD Vaccination and Post-Vaccination Monitoring in Afghanistan...EuFMD
 
LSD symposium - P. Malik - Lumpy skin disease experience from India
LSD symposium - P. Malik - Lumpy skin disease experience from IndiaLSD symposium - P. Malik - Lumpy skin disease experience from India
LSD symposium - P. Malik - Lumpy skin disease experience from IndiaEuFMD
 
FMD in North Africa and West Eurasia: The current threats to Europe
FMD in North Africa and West Eurasia: The current threats to EuropeFMD in North Africa and West Eurasia: The current threats to Europe
FMD in North Africa and West Eurasia: The current threats to EuropeEuFMD
 
Envenomation in India (2021): Antivenoms - Challenges and the way forward app...
Envenomation in India (2021): Antivenoms - Challenges and the way forward app...Envenomation in India (2021): Antivenoms - Challenges and the way forward app...
Envenomation in India (2021): Antivenoms - Challenges and the way forward app...Aldon Fernandes
 
1ST West Africa FMD Roadmap Meeting
1ST West Africa FMD Roadmap Meeting1ST West Africa FMD Roadmap Meeting
1ST West Africa FMD Roadmap MeetingExternalEvents
 
National Vector Born Disease Control Programme
National Vector Born Disease Control ProgrammeNational Vector Born Disease Control Programme
National Vector Born Disease Control ProgrammeKunal Modak
 
1 japanese encephalitis vaccination
1  japanese encephalitis vaccination1  japanese encephalitis vaccination
1 japanese encephalitis vaccinationRajesh Pandey
 
African Swine Fever (ASF) control: An entry point for enhancing human welfare...
African Swine Fever (ASF) control: An entry point for enhancing human welfare...African Swine Fever (ASF) control: An entry point for enhancing human welfare...
African Swine Fever (ASF) control: An entry point for enhancing human welfare...ILRI
 
West Eurasia Roadmap
West Eurasia RoadmapWest Eurasia Roadmap
West Eurasia RoadmapFAO
 
PEP_Prophylaxis_guideline_15_12_2014.pdf
PEP_Prophylaxis_guideline_15_12_2014.pdfPEP_Prophylaxis_guideline_15_12_2014.pdf
PEP_Prophylaxis_guideline_15_12_2014.pdfSheik4
 
OS20 - Foot-and-Mouth Disease risk mapping in Georgia - Tengiz Chaligava
OS20 - Foot-and-Mouth Disease risk mapping in Georgia - Tengiz ChaligavaOS20 - Foot-and-Mouth Disease risk mapping in Georgia - Tengiz Chaligava
OS20 - Foot-and-Mouth Disease risk mapping in Georgia - Tengiz ChaligavaEuFMD
 
07_thailand.pdf
07_thailand.pdf07_thailand.pdf
07_thailand.pdfPebisuseno
 
FMD in Nigeria (D. Lefebvre)
FMD in Nigeria (D. Lefebvre)FMD in Nigeria (D. Lefebvre)
FMD in Nigeria (D. Lefebvre)EuFMD
 
OS18 - 9.a.1 Serotypes in Nigeria - D. Lefebvre , A. Vleeschauwer & D. Ehizibolo
OS18 - 9.a.1 Serotypes in Nigeria - D. Lefebvre , A. Vleeschauwer & D. EhiziboloOS18 - 9.a.1 Serotypes in Nigeria - D. Lefebvre , A. Vleeschauwer & D. Ehizibolo
OS18 - 9.a.1 Serotypes in Nigeria - D. Lefebvre , A. Vleeschauwer & D. EhiziboloEuFMD
 

Similar to V. Basiladze - The PCP-FMD progress in Georgia and how it advances FAST control (20)

Current Management Status of Highly Pathogenic Avian Influenza (HPAI) in Nepal
Current Management Status of Highly Pathogenic Avian Influenza (HPAI) in NepalCurrent Management Status of Highly Pathogenic Avian Influenza (HPAI) in Nepal
Current Management Status of Highly Pathogenic Avian Influenza (HPAI) in Nepal
 
Current management status of highly pathogeni8c avian influenza (hpai) in nepal
Current management status of highly pathogeni8c avian influenza (hpai) in nepalCurrent management status of highly pathogeni8c avian influenza (hpai) in nepal
Current management status of highly pathogeni8c avian influenza (hpai) in nepal
 
Je vaccination bqa
Je vaccination bqaJe vaccination bqa
Je vaccination bqa
 
OS16 - 3.4.a FMD Vaccination and Post-Vaccination Monitoring in Afghanistan...
OS16 - 3.4.a   FMD Vaccination and Post-Vaccination Monitoring in Afghanistan...OS16 - 3.4.a   FMD Vaccination and Post-Vaccination Monitoring in Afghanistan...
OS16 - 3.4.a FMD Vaccination and Post-Vaccination Monitoring in Afghanistan...
 
LSD symposium - P. Malik - Lumpy skin disease experience from India
LSD symposium - P. Malik - Lumpy skin disease experience from IndiaLSD symposium - P. Malik - Lumpy skin disease experience from India
LSD symposium - P. Malik - Lumpy skin disease experience from India
 
FMD in North Africa and West Eurasia: The current threats to Europe
FMD in North Africa and West Eurasia: The current threats to EuropeFMD in North Africa and West Eurasia: The current threats to Europe
FMD in North Africa and West Eurasia: The current threats to Europe
 
Envenomation in India (2021): Antivenoms - Challenges and the way forward app...
Envenomation in India (2021): Antivenoms - Challenges and the way forward app...Envenomation in India (2021): Antivenoms - Challenges and the way forward app...
Envenomation in India (2021): Antivenoms - Challenges and the way forward app...
 
1ST West Africa FMD Roadmap Meeting
1ST West Africa FMD Roadmap Meeting1ST West Africa FMD Roadmap Meeting
1ST West Africa FMD Roadmap Meeting
 
National Vector Born Disease Control Programme
National Vector Born Disease Control ProgrammeNational Vector Born Disease Control Programme
National Vector Born Disease Control Programme
 
RABIES-new.pdf
RABIES-new.pdfRABIES-new.pdf
RABIES-new.pdf
 
1 japanese encephalitis vaccination
1  japanese encephalitis vaccination1  japanese encephalitis vaccination
1 japanese encephalitis vaccination
 
African Swine Fever (ASF) control: An entry point for enhancing human welfare...
African Swine Fever (ASF) control: An entry point for enhancing human welfare...African Swine Fever (ASF) control: An entry point for enhancing human welfare...
African Swine Fever (ASF) control: An entry point for enhancing human welfare...
 
Foot and Mouth Disese control strategies
Foot and Mouth Disese control strategiesFoot and Mouth Disese control strategies
Foot and Mouth Disese control strategies
 
West Eurasia Roadmap
West Eurasia RoadmapWest Eurasia Roadmap
West Eurasia Roadmap
 
PEP_Prophylaxis_guideline_15_12_2014.pdf
PEP_Prophylaxis_guideline_15_12_2014.pdfPEP_Prophylaxis_guideline_15_12_2014.pdf
PEP_Prophylaxis_guideline_15_12_2014.pdf
 
OS20 - Foot-and-Mouth Disease risk mapping in Georgia - Tengiz Chaligava
OS20 - Foot-and-Mouth Disease risk mapping in Georgia - Tengiz ChaligavaOS20 - Foot-and-Mouth Disease risk mapping in Georgia - Tengiz Chaligava
OS20 - Foot-and-Mouth Disease risk mapping in Georgia - Tengiz Chaligava
 
Malaria Disease
Malaria DiseaseMalaria Disease
Malaria Disease
 
07_thailand.pdf
07_thailand.pdf07_thailand.pdf
07_thailand.pdf
 
FMD in Nigeria (D. Lefebvre)
FMD in Nigeria (D. Lefebvre)FMD in Nigeria (D. Lefebvre)
FMD in Nigeria (D. Lefebvre)
 
OS18 - 9.a.1 Serotypes in Nigeria - D. Lefebvre , A. Vleeschauwer & D. Ehizibolo
OS18 - 9.a.1 Serotypes in Nigeria - D. Lefebvre , A. Vleeschauwer & D. EhiziboloOS18 - 9.a.1 Serotypes in Nigeria - D. Lefebvre , A. Vleeschauwer & D. Ehizibolo
OS18 - 9.a.1 Serotypes in Nigeria - D. Lefebvre , A. Vleeschauwer & D. Ehizibolo
 

More from EuFMD

VADEMOS VAccine Demand Estimation Model for FMD.pdf
VADEMOS VAccine Demand Estimation Model for FMD.pdfVADEMOS VAccine Demand Estimation Model for FMD.pdf
VADEMOS VAccine Demand Estimation Model for FMD.pdfEuFMD
 
Vaccine delivery and demand workshop
Vaccine delivery and demand workshopVaccine delivery and demand workshop
Vaccine delivery and demand workshopEuFMD
 
Emergency vaccination workshop presentations 30 May 2023.pdf
Emergency vaccination workshop presentations 30 May 2023.pdfEmergency vaccination workshop presentations 30 May 2023.pdf
Emergency vaccination workshop presentations 30 May 2023.pdfEuFMD
 
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...EuFMD
 
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...EuFMD
 
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...EuFMD
 
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...EuFMD
 
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...EuFMD
 
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...EuFMD
 
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...EuFMD
 
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...EuFMD
 
LSD symposium - L. Pite - Combating lumpy skin disease in Albania
LSD symposium - L. Pite - Combating lumpy skin disease in AlbaniaLSD symposium - L. Pite - Combating lumpy skin disease in Albania
LSD symposium - L. Pite - Combating lumpy skin disease in AlbaniaEuFMD
 
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...EuFMD
 
LSD symposium - J. Chan - Lumpy skin disease in Hong Kong
LSD symposium - J. Chan - Lumpy skin disease in Hong KongLSD symposium - J. Chan - Lumpy skin disease in Hong Kong
LSD symposium - J. Chan - Lumpy skin disease in Hong KongEuFMD
 
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...EuFMD
 
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...EuFMD
 
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...EuFMD
 
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...EuFMD
 
LSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
LSD symposium - E. Klemen - Modes of transmission of lumpy skin diseaseLSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
LSD symposium - E. Klemen - Modes of transmission of lumpy skin diseaseEuFMD
 
LSD symposium - A. Van Schalkwyk - Evolutionary changes between LSDV strains ...
LSD symposium - A. Van Schalkwyk - Evolutionary changes between LSDV strains ...LSD symposium - A. Van Schalkwyk - Evolutionary changes between LSDV strains ...
LSD symposium - A. Van Schalkwyk - Evolutionary changes between LSDV strains ...EuFMD
 

More from EuFMD (20)

VADEMOS VAccine Demand Estimation Model for FMD.pdf
VADEMOS VAccine Demand Estimation Model for FMD.pdfVADEMOS VAccine Demand Estimation Model for FMD.pdf
VADEMOS VAccine Demand Estimation Model for FMD.pdf
 
Vaccine delivery and demand workshop
Vaccine delivery and demand workshopVaccine delivery and demand workshop
Vaccine delivery and demand workshop
 
Emergency vaccination workshop presentations 30 May 2023.pdf
Emergency vaccination workshop presentations 30 May 2023.pdfEmergency vaccination workshop presentations 30 May 2023.pdf
Emergency vaccination workshop presentations 30 May 2023.pdf
 
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...
 
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...
 
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...
 
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...
 
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...
 
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...
 
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...
 
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...
 
LSD symposium - L. Pite - Combating lumpy skin disease in Albania
LSD symposium - L. Pite - Combating lumpy skin disease in AlbaniaLSD symposium - L. Pite - Combating lumpy skin disease in Albania
LSD symposium - L. Pite - Combating lumpy skin disease in Albania
 
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...
 
LSD symposium - J. Chan - Lumpy skin disease in Hong Kong
LSD symposium - J. Chan - Lumpy skin disease in Hong KongLSD symposium - J. Chan - Lumpy skin disease in Hong Kong
LSD symposium - J. Chan - Lumpy skin disease in Hong Kong
 
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...
 
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...
 
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
LSD symposium - G. Cattoli - Lessons from ten years of experience building me...
 
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...
 
LSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
LSD symposium - E. Klemen - Modes of transmission of lumpy skin diseaseLSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
LSD symposium - E. Klemen - Modes of transmission of lumpy skin disease
 
LSD symposium - A. Van Schalkwyk - Evolutionary changes between LSDV strains ...
LSD symposium - A. Van Schalkwyk - Evolutionary changes between LSDV strains ...LSD symposium - A. Van Schalkwyk - Evolutionary changes between LSDV strains ...
LSD symposium - A. Van Schalkwyk - Evolutionary changes between LSDV strains ...
 

Recently uploaded

Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsSérgio Sacani
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...anilsa9823
 
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfSwapnil Therkar
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxkessiyaTpeter
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxAleenaTreesaSaji
 
Boyles law module in the grade 10 science
Boyles law module in the grade 10 scienceBoyles law module in the grade 10 science
Boyles law module in the grade 10 sciencefloriejanemacaya1
 
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfNAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfWadeK3
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsAArockiyaNisha
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxSwapnil Therkar
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfnehabiju2046
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
VIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PVIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PPRINCE C P
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoSérgio Sacani
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝soniya singh
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real timeSatoshi NAKAHIRA
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
Animal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxAnimal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxUmerFayaz5
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTSérgio Sacani
 
Artificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PArtificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PPRINCE C P
 

Recently uploaded (20)

Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
 
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdfAnalytical Profile of Coleus Forskohlii | Forskolin .pdf
Analytical Profile of Coleus Forskohlii | Forskolin .pdf
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptx
 
Boyles law module in the grade 10 science
Boyles law module in the grade 10 scienceBoyles law module in the grade 10 science
Boyles law module in the grade 10 science
 
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdfNAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
NAVSEA PEO USC - Unmanned & Small Combatants 26Oct23.pdf
 
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdf
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
VIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PVIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C P
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on Io
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real time
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
Animal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxAnimal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptx
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOST
 
Artificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PArtificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C P
 

V. Basiladze - The PCP-FMD progress in Georgia and how it advances FAST control

  • 1. Activities in Regards of FMD in Georgia National Food Agency Vasili Basiladze Deputy head of NFA Chief Veterinary Officer, WOAH Delegate
  • 2. 1. FMD prophylactic vaccination in LR and SR; 2. FMD Risk assessment through ArcGIS; 3. FMD SP Sero-Surveillance in LR and SR; 4. FMD NSP Sero-Surveillance in LR and SR; 5. FMD Clinical investigation in candidate regions; 6. Evaluation of vaccine quality and immune responses; 7. Awareness campaign within the farmers; 8. Regional Simulation exercises; 9. Workshops and trainings; 10. OCP has been elaborated;
  • 3. • FMD risk based prophylactic vaccination has been conducted in LR and SR; • Eastern Georgia - Total number of animals (LR/SR); • Western Georgia - Animal located in high risk area (LR/SR); • Live animal markets, migrated animals, villages bordering with neighboring countries; villages bordering with occupied territory; 378991 975078 1528469 1617120 1533598 1465966 1000915 1280392 858000 865394 873901 624903 12960 127022 851576 998594 917336 1534680 1660625 1183095 1499333 1366515 1376350 1154528 0 500000 1000000 1500000 2000000 2500000 3000000 3500000 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 FMD Prophilactic Vaccination 2011-2022 LR SR
  • 4. • Animal Density SR/LR; • Seasonal Migration SR/LR; • Live Animal Market; • Vet inspection points; • Water sources; • International Trade; • Pasture; • Animal Market; • Quarantine Zones;
  • 5. • NSP sero- surveillance in Georgia has been conducting by four risk categories: • 1. Villages with high risk categories; • 2. Villages with low risk categories; • 3. Migrating animals in Eastern Georgia; • 4. Villages in Candidate Area. • NSP Sero- Surveillance – 5000 samples each year; • NSP Sero- Surveillance follow-up 500 samples each year; • SP Sero- Surveillance 500 samples each year;
  • 6. 15 12 6.6 8.2 5.3 4.3 5 47 46 75 39.1 62.9 71.2 70.8 0 10 20 30 40 50 60 70 80 0 2 4 6 8 10 12 14 16 2015 2016 2017 2018 2019 2020 2021 FMD SP and NSP Sero- surveillance 2015-2020 in Georgia Non Structural proteins Structural proteins
  • 7.
  • 8. Territory selection criteria: • Geographically isolated territories; • Only few entrance are available in both region; • Strict climatic conditions; • No Seasonal migration; • Low animal density (1,0 animals per 1 km2); • Historically favorable epizootic situation related to FMD; • Low prevalence of non-structural proteins; • 107 villages and 3 074 animals were investigated; • Data were entered in electronic system – Epicollect 5
  • 9.  VACCINE used in country - Sholkovo vaccine • Type O: PanAsia-2 • Type A: Iran 05; G-VII • Type Asia1: Shamir/Sindh-08  Sampling area were selected-based on following criteria; • Low NSP circulation area • Area with non vaccinated animals • Area existing with both specious (LR/SR) • Permission of sampling from animal owners involved in the trial
  • 10. The following protocol was elaborated • Species – large and small ruminants; • Status – animals with free from FMDV and antibodies, not vaccinated against FMD; • Age – six to Twelve months; • Number – totally 20 cattle and 20 sheep (9 vaccinated, 9 with revaccination and 2 control animals). • Animal identification – individually identified (ear tag); • Housing – animals should be kept in local area
  • 11. • SEROCONVERSION POST SINGLE VACCINATION:14 DPV 60-80% seropositive animals but very fast Ab decay (negative 90 DPV) • Low Ab levels • Insufficient immunity • BOOSTER VACCINATION: Significant Ab booster 30 days after revaccination, ALL positives above the presumed protection level • A booster vaccination is necessary to elicit a strong and fast rise of Ab; • Duration estimates should be planned; • SPECIES: better immune-response in SR than in LR after a single vaccination (particularly for serotype A and Asia1); opposite after booster vaccination.
  • 12. Hot line - 1501
  • 13. • First simulation exercise has been conducted in 2016; • Second simulation exercise has been conducted in 2019; • Next is planed in 2023;
  • 14. 0 100000 200000 300000 400000 500000 600000 700000 800000 2014 2015 2016 2017 2018 2019 2020 2021 2022 treatment Vaccination LSD Vaccination 2014-2020 • 400 000 doses LSD Vaccine (SGP strain) was purchased in 2020; • 200 000 doses LSD Vaccine (Neethling Strain) for was donated by EU in 2018/2020.
  • 15. 1650974 341461 399655 195978 279,382 712318 267933 0 200000 400000 600000 800000 1000000 1200000 1400000 1600000 1800000 2016 2017 2018 2019 2020 2021 2022 PPR prophylactic vaccination/re-vaccination in 2016-2022 • 267 933 SR were vaccinated/revaccinated in 2022; • Active sero-survey campaign (Project) conducted in Georgia which was funded by DTRA; • Totally 3 200 SR has been tested under this project; FAO has donated 400 000 doses PPR vaccine in 2020 FAO has donated 500 000 doses PPR vaccine in 2022
  • 16.
  • 17. System includes Veterinary, Human Health, Laboratories System ensures quick exchange of information and creation of database
  • 18. • Since 2018 year NAITS has been operating; Financed and Supported by Swiss and Austrian Development National Animal Identification and Traceability System
  • 19. Thank you for your attention